Adicon Holdings Ltd

Adicon Holdings Ltd has a debt-to-equity ratio of 0.96, indicating a moderate reliance on debt financing, and a current ratio of 1.44, suggesting adequate short-term liquidity to cover its obligations. The company's return on equity (ROE) is 1.07%, and return on assets (ROA) is 0.38%, both of which are below the industry median for Healthcare Facilities & Services, indicating weaker profitability relative to its peers. The company's gross profit margin is 36.1%, calculated from a gross profit of CNY 952.65 million on revenue of CNY 2.64 billion, but its operating margin is only 3.8%, with operating income of CNY 100.47 million. This suggests that the company is facing significant operating expenses relative to its gross profit, which may be a concern for long-term profitability. Adicon Holdings Ltd's revenue is concentrated in its core ICL services, with no disclosed geographic diversification in the provided data. The company operates primarily in China, and its business is subject to local regulatory and market conditions, which could affect its growth and stability. The company's revenue growth is not explicitly provided, but its operating cash flow of CNY 225.74 million and free cash flow of CNY 99.42 million indicate some level of cash generation. However, the capital expenditure of CNY -108.25 million suggests that the company is not investing heavily in new projects or infrastructure, which may limit its future growth potential. The risk assessment indicates a medium liquidity risk and a low dilution risk. However, the company has negative net cash after subtracting total debt, which could pose a challenge in maintaining liquidity under stress scenarios. The dilution risk is low, but the company's capital structure and leverage should be monitored for any changes that could affect shareholder value. Recent events include analyst price targets ranging from CNY 6.90 to CNY 9.00, with a mean of CNY 8.01 and a median of CNY 8.07. The mean recommendation is 1.50, indicating a generally positive outlook from analysts, with two strong-buy and two buy ratings.